Global Craniomaxillofacial Implants Market To Reach Worth US$ 2,842.2 Mn By 2025

According to the latest report published by Credence Research, Inc. “Craniomaxillofacial Implants Market – Growth, Future Prospects and Competitive Analysis, 2017-2025,” the global craniomaxillofacial implants market was valued at US$ 1,490.3 Mn in 2016, and is expected to reach US$ 2,842.2 Mn by 2025, expanding at a CAGR of 7.29% from 2017 to 2025.

Browse the full report Craniomaxillofacial Implants Market – Growth, Future Prospects and Competitive Analysis, 2017–2025 at

Market Insights                                   

Reconstructive craniomaxillofacial implant surgery comprises the use of implants and distraction systems to restore the form and function of damaged part of the craniomaxillofacial skeleton of the patients through fixed or removable prostheses. The use of such implants also aid in stabilizing prostheses that replace the missing facial and cranial parts. Reconstruction with implants assist patients in regaining normal functions such as speech, mastication and deglutition; resolve pain and gagging; and also improve facial symmetry and appearance. Increasing incidence of road accidents and sports injuries, growing demand for minimally invasive reconstructive surgeries and increasing prevalence of congenital facial deformities are the key factors driving the global craniomaxillofacial implants market. Furthermore, increasing awareness among consumers and surgeons about the availability of novel implants and reconstructive surgical methods is also driving the demand for craniomaxillofacial implants.

Based on the type of implants, the global craniomaxillofacial implants market is categorized into cranial implants, mandibular implants, distraction systems, dural repair implants, bone graft substitutes, and other implants and systems. Among these, distraction systems and mandibular implants experience the highest demand due to their efficacy in treating deformities, and wide usage in areas such as tumor removal, orthognathic surgery and congenital deformities. Mandibular implants segment will undergo rapid transition in terms of market growth and revenue generation due to increasing incidence of road accidents and combat sports injuries.

Metal, ceramic, and polymer and bioabsorbable material are the major material types used in manufacturing craniomaxillofacial implants. Metallic implants occupy the largest share in the global market due to their established properties such as less corrosion, less cost and more stability and support. Metals such titanium and its alloys are the most commonly used in craniomaxillofacial surgeries, particularly mandibular procedures. Additionally bioabsorbable and polymer materials are in high demand due to lesser chances of second surgery using these implants.

Between internal and external fixators, the internal fixators segment enjoys dominance in the global craniomaxillofacial implants market, whereas external fixators mainly find adoption in cranial surgeries. However, due to factors such advancement in the science of internal fixation, evolution of plating material, there has been a consistent increase in the demand for internal fixators for craniomaxillofacial procedures. Recently, manufacturers have developed interest in innovation in the field of resorbable rigid fixation systems. The introduction of internal rigid fixation techniques has assisted in increasing the success rate in repairing unstable or displaced facial fractures.

Geographically, North America (the U.S. and Canada) is observed to be the largest market for craniomaxillofacial implants. High incidence of facial trauma and congenital deformities majorly contribute to the dominance of this region. Rapid introduction of novel implant systems and growing demand for minimally invasive surgeries are some of the other factors driving the North America market. Additionally, Asia Pacific is estimated to be the fastest progressing regional market for craniomaxillofacial implants. Persistent increase in patient pool, evolution of healthcare infrastructure and rising awareness are the key factors that drive the craniomaxillofacial implants market in Asia Pacific.